×
About 53,393 results

ALLMedicine™ Anemia Center

Research & Reviews  16,794 results

Inter-arm blood pressure difference is associated with contrast-induced nephropathy in ...
https://doi.org/10.1080/10641963.2022.2029471
Clinical and Experimental Hypertension (New York, N.Y. : ... Simsek Z, Zehir R et. al.

Jan 22nd, 2022 - Contrast-induced nephropathy (CIN) is a serious complication in patients with ST segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (p-PCI). An interarm systolic blood pressure difference (IASBD) ...

Using Double-Fortified Salt to Reduce Iron Deficiency Anemia in India.
https://doi.org/10.1093/jn/nxab422
The Journal of Nutrition; Schultink JW

Jan 22nd, 2022 - Using Double-Fortified Salt to Reduce Iron Deficiency Anemia in India.|2022|Schultink JW,|

Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia
https://clinicaltrials.gov/ct2/show/NCT02162420

Jan 21st, 2022 - Fludarabine-based preparative regimen followed by an allogeneic hematopoietic stem cell transplant using related or unrelated donor in persons 0-70 years of age diagnosed with dyskeratosis congenita or severe aplastic anemia who have bone marrow f...

Potential of Prebiotic Galacto-oligosaccharides in Improving Efficacy and Safety of Oral Iron Supplementation in HIV-infected Children
https://clinicaltrials.gov/ct2/show/NCT04931641

Jan 21st, 2022 - Iron deficiency anemia (IDA) in childhood can impair growth and cognition, as well as reduce school performance. Furthermore, anemia frequently complicates pediatric HIV infection and predicts disease progression and mortality. However, there is n...

see more →

Guidelines  25 results

Controversies in optimal anemia management: conclusions from a Kidney Disease: Improvin...
https://doi.org/10.1016/j.kint.2021.03.020
Kidney International; Babitt JL, Eisenga MF et. al.

Apr 12th, 2021 - In chronic kidney disease, anemia and disordered iron homeostasis are prevalent and associated with significant adverse consequences. In 2012, Kidney Disease: Improving Global Outcomes (KDIGO) issued an anemia guideline for managing the diagnosis,...

Spotlight: Gastrointestinal Evaluation of Iron Deficiency Anemia.
https://doi.org/10.1053/j.gastro.2020.08.036
Gastroenterology Ko CW, Siddique SM et. al.

Aug 31st, 2020 - Spotlight: Gastrointestinal Evaluation of Iron Deficiency Anemia.|2020|Ko CW,Siddique SM,Patel A,Harris A,Altayar O,|blood,diagnosis,etiology,standards,standards,standards,diagnostic imaging,metabolism,pathology,standards,blood,complications,diagn...

GI Evaluation of Iron Deficiency Anemia: Clinical Decision Support Tool.
https://doi.org/10.1053/j.gastro.2020.08.043
Gastroenterology

Aug 31st, 2020 - GI Evaluation of Iron Deficiency Anemia: Clinical Decision Support Tool.|2020| ,|blood,diagnosis,etiology,standards,methods,standards,standards,diagnostic imaging,metabolism,pathology,standards,blood,complications,diagnosis,pathology,analysis,diag...

AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency ...
https://doi.org/10.1053/j.gastro.2020.06.046
Gastroenterology Ko CW, Siddique SM et. al.

Aug 19th, 2020 - AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency Anemia.|2020|Ko CW,Siddique SM,Patel A,Harris A,Sultan S,|blood,diagnosis,epidemiology,etiology,standards,standards,diagnostic imaging,metabolism,pathology,stan...

Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH...
https://doi.org/10.1200/JCO.18.02142
Journal of Clinical Oncology : Official Journal of the Am... Bohlius J, Bohlke K et. al.

Apr 11th, 2019 - To update the American Society of Clinical Oncology (ASCO)/American Society of Hematology (ASH) recommendations for use of erythropoiesis-stimulating agents (ESAs) in patients with cancer. PubMed and the Cochrane Library were searched for randomiz...

see more →

Drugs  734 results see all →

Clinicaltrials.gov  911 results

Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia
https://clinicaltrials.gov/ct2/show/NCT02162420

Jan 21st, 2022 - Fludarabine-based preparative regimen followed by an allogeneic hematopoietic stem cell transplant using related or unrelated donor in persons 0-70 years of age diagnosed with dyskeratosis congenita or severe aplastic anemia who have bone marrow f...

Potential of Prebiotic Galacto-oligosaccharides in Improving Efficacy and Safety of Oral Iron Supplementation in HIV-infected Children
https://clinicaltrials.gov/ct2/show/NCT04931641

Jan 21st, 2022 - Iron deficiency anemia (IDA) in childhood can impair growth and cognition, as well as reduce school performance. Furthermore, anemia frequently complicates pediatric HIV infection and predicts disease progression and mortality. However, there is n...

Patient Blood Management Charité (PBM-Charité): Structured Detection, Differentiated Diagnostics and Therapy of Preoperative Anemia and Use of Machine Autotransfusion in Elective Interventions
https://clinicaltrials.gov/ct2/show/NCT05146726

Jan 21st, 2022 - Background of this multimodal, multidisciplinary concept are numerous studies that have shown an association between preoperative anemia and/or a perioperative transfusion and a worse treatment outcome concerning morbidity and mortality. Diagnosis...

( Comparison Between ) Conventional and Modified Smead Jones Method for Abdominal Mass Closure in Emergency Midline Laparotomy
https://clinicaltrials.gov/ct2/show/NCT05199974

Jan 20th, 2022 - The occurrence of sudden disruption of abdominal wall laparotomy wound is a major disaster and a major psychological trauma to the patient . Acute wound dehiscence is defined as postoperative separation of the abdominal musculoaponeurotic layers w...

Hemolysis Related Complications in SCD. A Phase II Study With Voxelotor
https://clinicaltrials.gov/ct2/show/NCT05199766

Jan 20th, 2022 - Intro: Sickle cell disease is a genetic disorder caused by a mutation of the β hemoglobin called HbS, which causes red blood cell (RBC) abnormalities responsible for hemolysis, mainly intravascular, leading to chronic anemia. Intravascular hemolys...

see more →

News  2,805 results

Olaparib Plus Pembrolizumab Demonstrates Manageable AEs in Advanced Cholangiocarcinoma
https://www.onclive.com/view/olaparib-plus-pembrolizumab-demonstrates-manageable-aes-in-advanced-cholangiocarcinoma

Jan 22nd, 2022 - The combination of olaparib (Lynparza) and pembrolizumab (Keytruda) demonstrated acceptable safety and an manageable adverse effect (AE) profile in patients with advanced cholangiocarcinoma who had received prior gemcitabine-based therapy, accordi...

Pembrolizumab/Chemo Combo Emerges as Standard of Care in Esophageal Cancer/GEJ Adenocarcinoma
https://www.onclive.com/view/pembrolizumab-chemo-combo-emerges-as-standard-of-care-in-esophageal-cancer-gej-adenocarcinoma

Jan 21st, 2022 - First-line pembrolizumab (Keytruda) plus chemotherapy continued to maintain clinically significant benefit in patients with locally advanced and metastatic esophageal cancer—including gastroesophageal junction (GEJ) adenocarcinoma, across all subg...

Nivolumab/Chemo Combo Maintains Clinical Efficacy at 2 Years in Gastric/GEJ Cancer
https://www.onclive.com/view/nivolumab-chemo-combo-maintains-clinical-efficacy-at-2-years-in-gastric-gej-cancer

Jan 21st, 2022 - Nivolumab (Opdivo) plus chemotherapy demonstrated a durable survival benefit for patients with gastric or gastroesophageal junction (GEJ) cancer, according to updated findings from the CheckMate 649 trial (NCT02872116) presented at the 2022 Gastro...

Oral Fluoropyrimidine Improves Survival as Adjuvant Therapy in Biliary Tract Cancer
https://www.onclive.com/view/oral-fluoropyrimidine-improves-survival-as-adjuvant-therapy-in-biliary-tract-cancer

Jan 21st, 2022 - The oral fluoropyrimidine derivative S-1 led to improved survival when used as adjuvant therapy compared with surgery alone in patients with biliary tract cancers, according to findings from a phase 3 trial (UMIN000011688) that were presented duri...

Adagrasib Monotherapy Elicits High Rates of Disease Control in KRAS-Mutated PDAC and Other GI Malignancies
https://www.onclive.com/view/adagrasib-monotherapy-elicits-high-rates-of-disease-control-in-kras-mutated-pdac-and-other-gi-malignancies

Jan 21st, 2022 - Adagrasib monotherapy demonstrated encouraging clinical activity in patients with previously treated pancreatic ductal adenocarcinoma (PDAC) and other non–colorectal gastrointestinal tumors that harbor KRAS G12C mutations, according to results of ...

see more →

Patient Education  88 results see all →